Dergiler / Turkish Journal of Medical Sciences / 2012 / Cilt: 42 - Sayı: 5

The effects of stobadine on purine metabolism in rats treated with carbon tetrachloride

Sayfa
894–900
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It is suggested that the inhibition of key enzymes of the purine degradation pathway (particularly ADA and XO) may prevent liver damage.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The aim of the present study was to investigate the relationship between liver damage induced by carbon tetrachloride (CCl4) and adenosine deaminase (ADA), 5'-nucleotidase (5'NT), xanthine oxidase (XO) enzyme activities, and malondialdehyde (MDA) levels.
📊
Temel Bulgular & Veri:Materials and methods: This study measured the effect of CCl4 on ADA, 5'NT, XO enzyme activities, and MDA levels, and measured the histopathologic changes in liver cells.
💡
Sonuç & Katkı:It is suggested that the inhibition of key enzymes of the purine degradation pathway (particularly ADA and XO) may prevent liver damage.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Key words: CCl4 · adenosine deaminase · 5'-nucleotidase

Özet

The aim of the present study was to investigate the relationship between liver damage induced by carbon tetrachloride (CCl4) and adenosine deaminase (ADA), 5'-nucleotidase (5'NT), xanthine oxidase (XO) enzyme activities, and malondialdehyde (MDA) levels. The effect of stobadine on purine metabolism was also evaluated. Materials and methods: This study measured the effect of CCl4 on ADA, 5'NT, XO enzyme activities, and MDA levels, and measured the histopathologic changes in liver cells. Results: Our research found that ADA, XO activities, and MDA levels increased in the CCl4 group when compared with the control group. This was also supported by the histopathological changes in the CCl4 and CCl4+stobadine group found when compared with the control group. Stobadine could not protect cells against CCl4 damage. Conclusion: The present study helps explain the biochemical mechanisms of liver injury formed by CCl4 and shows the relationship between the purine degradation pathway and CCl4induced cellular toxic effect. Cellular damage is dependent upon the biochemical response to increased purine degradation pathway enzyme activities, which also may be responsible for decreasing liver cellular adenosine levels and S-adenosyl-methionine and increasing superoxide anion and hydrogen peroxide levels. It is suggested that the inhibition of key enzymes of the purine degradation pathway (particularly ADA and XO) may prevent liver damage.

Abstract

The aim of the present study was to investigate the relationship between liver damage induced by carbon tetrachloride (CCl4) and adenosine deaminase (ADA), 5'-nucleotidase (5'NT), xanthine oxidase (XO) enzyme activities, and malondialdehyde (MDA) levels. The effect of stobadine on purine metabolism was also evaluated. Materials and methods: This study measured the effect of CCl4 on ADA, 5'NT, XO enzyme activities, and MDA levels, and measured the histopathologic changes in liver cells. Results: Our research found that ADA, XO activities, and MDA levels increased in the CCl4 group when compared with the control group. This was also supported by the histopathological changes in the CCl4 and CCl4+stobadine group found when compared with the control group. Stobadine could not protect cells against CCl4 damage. Conclusion: The present study helps explain the biochemical mechanisms of liver injury formed by CCl4 and shows the relationship between the purine degradation pathway and CCl4induced cellular toxic effect. Cellular damage is dependent upon the biochemical response to increased purine degradation pathway enzyme activities, which also may be responsible for decreasing liver cellular adenosine levels and S-adenosyl-methionine and increasing superoxide anion and hydrogen peroxide levels. It is suggested that the inhibition of key enzymes of the purine degradation pathway (particularly ADA and XO) may prevent liver damage.

🔖

Bu Makaleye Atıf Yap

GÜMÜŞLÜ, S., ÖMEROĞLU, S., DUYGULU, S. D., KAVUTÇU, M., BAYRAKTAR, N., YAVUZ, M. T., CANBOLAT, O. (2022). The effects of stobadine on purine metabolism in rats treated with carbon tetrachloride. Turkish Journal of Medical Sciences, Cilt: 42 - Sayı: 5, 894–900. https://ajindex.com/articles/611243

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli P et al. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology 1992; 16: 1014-21
  2. Hernandez-Munoz R, Diaz-Munoz M, Lopez V, LopezBarrera F, Yanez L, Virdio S et al. Balance between oxidative damage and proliferative potential in an experimental rat model of CCl4 -induced cirrhosis. Protective role of adenosine administration. Hepatology 1997; 26: 1100-10
  3. Poli G, Cottalasso D, Pronzato MA, Chiarpotto E, Marinari UM. Lipid peroxidation and covalent binding in early functional impairment of liver Golgi apparatus by carbon tetrachloride. Cell Biochem Func 1990; 8: 1-10
  4. Recknagel R, Glende EA, Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharma Th er 1989; 43: 139-54
  5. Slater TF. Free radicals as reactive intermediates in injury. In: Snyder IR, Parke DV, Kocsis JJ, Jollow DJ, Gibson GG, Witmer CM, editors. Biological reactive intermediates II: chemical mechanisms and biological eff ects. New York: Plenum Press; 1982. p.575-89
  6. Arii S, Monden K, Hai S, Sasaoki T, Adachi Y, Funaki N et al. Depressed function of Kupff er cells in rats with CCl4 -induced liver cirrhosis. Res Exp Med 1990; 190: 173-82
  7. Canbolat O, Durak I, Cetin R, Kavutcu M, Demirci S, Oztürk S. Activities of adenosine deaminase, 5’-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and noncancerous human breast tissues. Breast Cancer Res Treat 1996; 37: 189-93
  8. Durak I, Işik AC, Canbolat O, Akyol O, Kavutçu M. Adenosine deaminase, 5’-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues. Free Radic Biol Med 1993; 15: 681-4
  9. Murray JL, Mehta K, Lopez-Berestein G. Induction of adenosine deaminase and 5’-nucleotidase activity in cultured human blood monocytes and monocytic leukemia (THP-1) cells by diff erentiating agents. J Leukoc Biol 1988; 44: 205-11
  10. Iizuka H, Koizumi H, Kamigaki K, Aoyagi T, Miura Y. Two forms of adenosine deaminase in pig epidermis. J Dermatol 1981; 8: 91-5
  11. Donofrio J, Coleman MS, Hutton JJ, Daoud A, Lampkin B, Dyminski J. Overproduction of adenosine deoxynucleosides and deoxynucleotides in adenosine deaminasedefi ciency with severe combined immunodefi ciency disease. J Clin Invest 1978; 62: 884-7
  12. Chang PK, Gordon RK, Tai J, Zeng GC, Doctor BP, Pardhasaradhi K et al. S-adenosylmethionine and m